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INTRODUCTION 
  
                Diabetes is a common disease causing lower extremity amputation 
throughout the world, particularly in India, the Diabetic capital of the world. 
By 2025, it is estimated that India will have world‘s majority of diabetics. 
Diabetes Mellitus is the most important cause of non-traumatic amputations 
worldwide. Amputations are perhaps the most feared complication of Diabetes. 
                In 2011 around 8.3% of world population had diabetes. Among these, 
vast majority were inhabiting in developing nations. It is projected that by the 
year 2030, around 10% of the human race would become diabetics. The 
troublesome fact is that this disease is being diagnosed more and more in the 
younger population of the world. Each year, over one million amputations are 
being performed to alleviate disease caused by diabetes. This roughly works out 
as one amputation in the world every 30 seconds. The predisposing factors that 
lead to amputation are diabetic neuropathy, bony deformities, inconspicuous 
trauma, and vascular diseases. In the presence of an ulcer, local sepsis and 
vascular insufficiency are major causes of amputation. The presentation of 
lesions greatly differ based on socio-economic status, quality of foot care and 
usage of footwear. It has been projected that one in six diabetics living in 
developed nations will develop ulceration before they die. This problem is even 
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more menacing in developing nations. Diabetic foot not only affects the 
individual but also their family and the community as a whole. It causes great 
strain on the financial and health care infra-structure of the nation. Another 
cause of concern is the emergence of type 2 Diabetes in children. These cases 
will eventually progress to develop micro and macrovascular complications 
including life-threatening infections at an early age. Around 25% of these cases 
will be non-healing and upto 28% will end up in amputation. Investing in a 
scientific foot care techniques and guidelines will be more cost effective in the 
long run. Amputations alter quality of life and longevity. Amputations are 
associated with an increased risk of re-amputation and at an increased 
mortality in first decade after amputation. Early diagnosis and prompt therapy is 
mandatory. A team approach can reduce the number of amputations. Adequate 
infra-structure and facilities are essential. However, ignorance on the part of the 
patients and also the health care provider has made this goal hard to attain. 
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AIMS  AND  OBJECTIVES  OF  THE  STUDY 
 
1.  To  formulate  a  scoring  system  using  various  contributory  factors  
for  early  detection  of  unsalvageable  diabetic  foot  in  our  locality. 
2.  To  analyse  those  various  factors  which  contribute  to  major  
amputations  in  lower  extremity  in  diabetic  foot  patients. 
3.  To  study  about  common  bacterial  organisms  which  complicate  
diabetic  wounds  and  their  antibiotic  sensitivity  pattern  using  tissue  
cultures  in  our  locality. 
 
DESIGN  OF  STUDY 
          Prospective  observational  study 
 
PERIOD  OF  STUDY 
               March 2015 to September 2016 
 
 
 
4 
 
SELECTION  OF  STUDY 
               Inclusion  criteria 
x All  adult  patients  with  diabetic  foot  infections  admitted  
in  Dept. of  General  Surgery,  Govt.  Rajaji  Hospital,  
Madurai  during  the  period  of  study. 
                 Exclusion criteria 
x Immunocompromised  individuals  like  HIV,  TB,  
Malignancy. 
x Those  who  are  not  willing  to  participate  in  the  study. 
x Those who expired during  the  stay  at  hospital.          
CONSENT 
           Individual  written  and  informed  consent 
COLLABORATIVE  DEPARTMENT 
          Department  of  Microbiology 
PARTICIPANTS 
            All patients  from  casualty,  surgery  OPD  and  ward  admitted  with  
diabetic  foot  infections  at  Govt.  Rajaji  Hospital ,  Madurai 
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METHODOLOGY 
SOURCE  AND  DATA 
               All patients  diagnosed  to  have  diabetic  foot  infection. 
METHODS  OF  COLLECTION  OF  DATA 
1. Details  of  cases 
2. Full  history 
3. Clinical  examination 
4. Biochemical  investigations 
5. Radiological  investigations 
6. Bacteriological  tissue  culture 
CLINICAL  EXAMINATION 
          Complete  inspection  and  palpation  of  the  ulcer  especially  for 
presence  of  gangrene,  pulse  status  of  concerned  part,  ankle  brachial  index 
(ABI)  and  bony  involvement. 
BIOCHEMICAL  INVESTIGATION 
1. Hb% 
2. TC/DC 
3. ESR 
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4. CRP 
5. LIPID  PROFILE 
6. RENAL  FUNCTION  TESTS 
RADIOLOGICAL  INVESTIGATION 
          X-ray  of  concerned  local  part 
BACTERIOLOGICAL  TISSUE  CULTURE 
         Gram  positive  and  gram  negative  bacteria  and  their  antibiotic  
sensitivity  pattern. 
CARDIOVASCULAR  SYSTEM 
          Echocardiogram 
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DIABETES MELLITUS - HISTORY 
 
Diabetes  as  a  disease  started  in  approximately  1550BC.  Egyptian  Papyrus  
records  it  as  a  disease  that causes rapid weight loss and frequent urination. 
Greek physician Aretaeus of Cappodoc IA(81-133AD) described it as a disease 
in which limbs and flesh melt down meaning  ―a flowing through‖.  Galen said, 
Diabetes disease  process has an affliction to the kidneys. The term Diabetes 
was coined by  Appllonius Memphites. The term Mellitus was coined by 
Thomas Willis meaning  ―honey sweet‖ in 1675.  In1776 Dapson  first 
demonstrated excretion of large amounts of sugar in urine & circulating blood 
in diabetic patients . The discovery of  Glycogenesis in  Liver is a landmark in 
history of Diabetes. Claude Bernard said, diabetes is caused by high glucose 
synthesis, in 1800‘s. During 18th and early 19th century  glycosuria has been 
accepted as a diagnostic feature of Diabetes due to metabolic derangement. In 
1869-Islets cells were discovered in pancreatic tissue by Paul Langerhans. 
Pancreas as pivotal in causation of the disease was elucidated by Mering & 
Minkowski in 1889.  Discovery of Insulin and its practical application by 
Banting and Best 1921 is a major milestone. Roger Hirsworth discovered two 
types of Diabetes in 1935. In 1950, oral medications of Diabetes came into 
existence.  In 1961,first injection of Insulin was developed by  Decton-Dickson. 
Various researches are going on for the treatment of Diabetes. 
8 
 
REVIEW OF LITERATURE 
 
HISTORICAL ASPECT OF DIABETIC FOOT 
      In 19th and 20th century, disease of lower limb in diabetic patients was  
designated as 'gangrene in diabetic foot' or as 'diabetic gangrene'. The  
significant distinction between gangrene due to Vascular insufficiency and  
gangrene due to infection in the limb with a normal or near normal blood  
supply was not made until 1893. 
                  Aseptic surgery improved the survival of amputation flaps.  
Diabetic foot disease is the major cause of diabetic mortality surpassing  
hyperglycemia coma at present. 
                The discovery of insulin has reduced the need of intervention to  
some extent. The major cause of diabetic foot disease were infection  
ischemia and neuropathy. The emphasis on preventive care and health  
education about diabetes should be appreciated. 
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EPIDEMIOLOGY OF DIABETICS AND DIABETIC FOOT IN INDIA 
               In 2002 in India about 32million people were affected by diabetes.  
The international diabetes federation estimated about 40.9million diabetic  
patients in India and also estimated that it will rise up to 69.9million in 2015. 
              In India about 3.6percent people are affected by diabetic foot ulcers  
in clinic population. Factors such as walking on barefoot rituals like walking  
on fire, ill fitting shoes and chapels and poor knowledge regarding foot care  
leads to increase incidence of diabetic foot complications in India. 
                           
INTRODUCTION TO DIABETIC FOOT 
                 Foot ulcers, microbial infection  and Charcot neuropathic  
Osteoarthopathy  are the three major foot complications of diabetes that  
will mostly lead to gangrene and hence to amputation. As a result they are  
one of the major causes of hospitalization for diabetic patients which can  
lead to huge expenditure for the country every year. A multidisciplinary team  
approach tends to decrease the complications of diabetic foot to major extent.  
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The pathophysiology of diabetic foot should be well  understood to treat or to 
prevent diabetic foot and its major complications. 
 
WHO DEFINITION OF DIABETIC FOOT 
            The foot of a  patient that has a potential risk of pathologic  
consequences including infection, ulceration, and/or destruction of deep  
tissues associated with neurological abnormalities, various degrees of  
peripheral vascular disease and /or metabolic complications of diabetes in 
 the lower limb. 
 
ETIOLOGY AND RISK FACTORS 
           The most common precursor for lower limb amputations in diabetic  
patients is foot ulceration. The various risk factors attributed to diabetic  
foot are peripheral neuropathy,vascular disease, restricted joint mobility,  
foot deformities, abnormal foot pressures,minor trauma, previous history  
of ulceration or amputation and defective vision. 
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RISK  FACTORS  FOR  ULCERATION 
1. Peripheral sensory neuropathy 
2. Structural foot deformity 
3. Injury and ill fitting shoes 
4. Callosities 
5. Previous ulcers/amputation 
6. Abnormal foot pressures  
7. Restricted joint mobility 
8. Elevated blood glucose levels 
9. Duration of diabetes 
10. Impairment of vision 
11. Extremes of age 
12. Other comorbidities 
 
             Peripheral neuropathy in the absence of trauma is the major factor  
for diabetic foot ulcerations. This was revealed by recent multicentric  
studies. Around 45-60percent of diabetic ulceration are purely neuropathic,  
while 30 -45percent have booth neuropathic and ischemic components. 
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           Motor neuropathy will result in atrophy of anterior crural muscles,   
hence muscle wasting may lead to foot drop,equinus hammertoes,  
prominent planter metatarsal heads. 
             Autonomic neuropathy may lead to dry skin which in turn leads to  
cracking and fissuring which creates a port for entry of bacteria. 
 Autosympathectomy associated with sympathetic failure, arteriovenous  
shunting, micro vascular thermo regulatory dysfunction impairs perfusion  
of normal tissues and microvascular responses to injury. All these  
processes will subsequently leads to ulceration. 
            Foot deformities, abnormal biomechanics, congenital disorders, or  
previous surgery will lead to high focal foot pressures. All these factors  
leads to vulnerable areas in the foot predisposing to ulceration. Although  
plantar aspect of foot is commonly affected, footwear irritation may  
cause ulceration in dorsal and medial aspect of foot. Such deformities  
might include prior partial amputation, prominent metatarsal heads,  
hammer toes, Charcot arthropathy, or hallux valgus. 
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              Foot trauma in a patient with  peripheral sensory neuropathy is a  
significant cause of ulceration. Besides puncture wounds and blunt injuries 
 to the foot, Even trivial trauma such as repetitive stress from walking and  
day to day activities will lead to callus formation. Ill fitting shoes which may 
 lead to trauma to a foot may add insult to injury in turns leads to ulceration. 
 
            Peripheral vascular disease as such does not cause ulcers directly in  
a diabetic foot. But once ulcer develops then arterial insufficiency will lead 
 to prolonged healing and causes an increased risk for amputations. And in 
 addition to that infections are very difficult to treat due to poor  
oxygenation and poor delivery of antibiotics to the infection site owing to  
arterial insufficiency. And hence early recognition and aggressive treatment 
 of lower extremity ischemia is therefore vital in lower limb salvage. 
              Restricted joint mobility is now described as a potential risk for  
ulcers. Cheiroarthropathy is the stiffening of capsular structures and  
ligaments which is due to glycosylation of collagen in patients with long  
standing diabetes mellitus. The subsequent reduction in ankle, subtalar,  
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first metatarsophalangeal joint mobility has shown to result in high focal 
 pressures with increased risk of ulceration. 
 
MECHANISM OF INJURY 
                 Diabetic foot ulcers have multi factorial etiology. Foot deformities 
 and neuropathy cause skin breakdown in persons with diabetes by the  
following two mechanisms. 
x Injuries due to continuous low pressure (ill fitting shoes). 
x Injuries due to chronic repetitive trauma from walking. 
 
               Prolonged low pressure over bony prominence (i.e., bunion or hammer  
toe deformities). Various studies shows shoe trauma in association with  
loss of protective sensation and concomitant foot deformity, are major 
 precipitating events leading to foot ulceration in diabetes. 
 
         Prolonged repetitive moderate stress normally occurs over the sole of  
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foot and is related to prominent metatarsal heads, atrophied or anteriorly  
displaced fat pads, structural deformity of the lower extremities, and  
prolonged walking. Rigid deformities such as hallux valgus, hallux rigidius,  
hammer toes and limited range of motion of ankle subtalar and  
metatarsophalangeal joints also may lead to the development of ulceration  
in diabetic foot patients. Other biomechanical perturbations including  
partial foot amputations, also will have the same adverse effects in  
diabetic foots. 
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ANATOMY  OF  LOWER  LIMB 
ANATOMY  OF  THE  SOLE  OF  THE  FOOT 
 
SKIN 
            It is thick , firmly attached to the deep fascia by fibrous bands. sweat 
glands are present in large numbers. The sensory nerve supply to the medial 
skin of sole is derived from the tibial nerve, lateral part of the sole is 
innervated by corresponding plantar nerve,and its Medial two thirds is 
innervated by medial plantar nerve. 
 
DEEP FASCIA 
           Deep transverse metatarsal ligaments and aponeurosis together constitute 
deep fascia. Flexor retinaculam extends from the Medial malleolus to the 
medial surface of calcaneum. It attaches the tendons of deep muscles to the 
medially in the ankle. The aponeurosis occupies the central area of Sole, 
triangular in shape and its apex is attached to the calcaneum, and its base 
attached to the toes. Each slip has two bands, passing superficially to the skin 
and deeply to the root of toe. Fibrous septa form the fascial spaces of sole, 
gives firm attachment to the overlying skin. It protects the underlying vessels, 
tendons, nerves. It helps to maintain the arches in the foot. 
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THIRD   LAYER 
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MUSCLES OF THE SOLE 
They are divided into four layers. 
I Layer      Abductor hallucis 
                   Abductor digiti minimi 
                   Flexor digitorum brevis 
 
II Layer      Lumbricals 
                    Flexor hallucis longus 
                    Flexor digitorum longus 
 
III Layer    Flexor hallucis brevis 
                    Flexor digiti minimi brevis 
                    Adductor hallucis 
 
IV Layer    Interossei 
                   Tibialis posterior 
                   Peroneus longus 
  
ARTERIAL SUPPLY 
1.Medial  Plantar  Artery 
Medial side of toe is supplied by MPA, gives off numerous cutaneous, muscular 
and articular branches. 
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2.Lateral Plantar Artery 
Plantar arch is supplied by LPA. Plantar arch gives digital arteries to lateral side 
of the small toe and both sides of four lateral toes. 
 
3.Dorsalis Pedis Artery(DPA) 
DPA joins with the plantar artery on the lateral aspect and supplies plantararch . 
Its branches are 
-Lateral tarsal artery 
-First dorsal metatarsal artery which supplies both side of big toe. 
-Arcuate artery supplies metatarsal branches to the toes. 
Medial and lateral plantar veins accompany the corresponding arteries and join 
behind the medial malleolus to form the posterior tibial venae commitanes. 
 
NERVE SUPPLY 
 
1. Lateral Plantar Nerve 
Supplies flexor digit minimi, abductor hallucis, quadaratus, plantaris, abductor 
digiti minimi, second and third and fourth lumbricals and all interossei. It 
supplies cutaneous twigs to the skin sole on lateral aspect, one and half toes on 
the lateral aspect and its nail beds and tips. 
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2.Medial Plantar Nerve 
Supplies muscular branches to abductor hallusis, flexor hallusis brevis, flexor 
digitorum brevis. It also supplies cutaneous branches to medial three and half 
toes and its corresponding nail beds and tips. 
 
DORSUM OF THE FOOT 
SKIN 
Skin on the dorsal aspect is freely mobile on the underlying tendons and 
bones. Sensory nerve supply to the dorsum is derived from the superficial 
peroneal nerve. It also receives sensory innervations by deep 
peroneal,saphenous, sural nerves.The skin covering the dorsal surfaces of 
terminal phalanges, nail beds are supplied by medial and lateral plantar nerves. 
Knowledge of the spaces of the foot is very important because infections in any 
of the spaces result in extension along fascia or tendon. The four medial spaces 
can be approached from inside of the foot by an incision along inner border of 
first metatarsal bone. The digital vessels arise from dorsal arch pass via 
intermetatarsal ligaments to the toes. Infection of the toe or web space if not 
adequately controlled spreads deeper. It reaches the tendon sheaths of long 
flexors or lumbricals and spread to 3rd layer. Very high pressure build up in the 
closed area because of pus, edema, and presence of gas forming organisms. This 
causes tissue necrosis and mechanical pressure on digital vessels leads to 
gangrene of the foot. 
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DORSUM  OF  THE  FOOT 
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ANATOMY OF THE LEG 
 
Superficial fascia 
Contains superficial veins like great saphenous vein, short saphenous vein, 
cutaneous nerves like infrapatellar branch of saphenous nerve, saphenous 
nerve,lateral cutaneous nerve of calf, superficial peroneal nerve, sural nerve, 
lymphatics, and small unnamed arteries. 
 
Deep fascia 
Extension of deep fascia form the septa divide the leg into three compartments 
anterior, posterior and lateral. 
 
Anterior compartment 
Muscles               Tibialis anterior 
                             Extensor hallucis longus 
                             Extensor digitorum longus 
                             Peroneus tertius 
Vessels                Anterior Tibial vessels 
Nerve                  Deep peroneal nerve 
Lateral Compartment 
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Muscles              Peroneus longus 
                            Peroneus brevis 
Nerve                  Superficial peroneal nerve 
Vessels                Peroneal vessels 
 
MEDIAL SIDE OF THE LEG 
Formed by medial surface of the shaft of tibia. The greater part of this surface 
is subcutaneous and is covered by skin and superficial fascia. Three muscles are 
inserted into the upper part of medial surface of the tibia from three 
compartments of the thigh namely Sartorius, gracilis, and semitendinosus 
forming Guy ropes. 
 
BACK OF THE LEG 
Superficial fascia of the back of the leg contains small and great 
saphenous veins and their tributaries, several cutaneous nerves,and medial and 
lateral calcaneal arteries. 
Superficial muscles of this area are 
• Gastronemius 
• Soleus 
• Plantaris 
Nerve supply to superficial muscles of the back is Tibial nerve. 
Posterior group of muscles that are present in deep aspect are 
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• Popliteus 
• Flexor digitorum longus 
• Flexor hallucis longus 
• Tibialis posterior 
Vascular supply to this area by Posterior tibial vessels. 
 
ANATOMY OF THE THIGH 
FRONT OF THE THIGH 
The superficial fascia of the front of the thigh contains great saphenous vein, 
cutaneous nerves, vessels, lymphatics and lymph nodes.The upper third of the 
thigh medially contains the femoral triangle, middle third carries the femoral 
vessels through the adductor canal. Muscles of the frontal aspect of the thigh are 
• Sartorius 
• Rectus femoris 
• Vastus lateralis 
• Vastus intermedius 
• Vastus medialis 
Nerve supply : Femoral Nerve 
 
MEDIAL ASPECT OF THE THIGH 
Muscles 
Adductor longus 
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Adductor brevis 
Adductor magnus 
Gracilis 
Pectineus 
Obturator externus 
Nerve supply 
Obturator nerve 
Accessory obturator nerve 
Arterial supply 
Obturator artery 
Medial circumflex femoral artery 
 
BACK OF THE THIGH 
Muscles 
Semitendinosus 
Semimembranosus 
Biceps femoris 
Nerve supply Sciatic nerve 
Vascular supply 
Lateral circumflex femoral 
Medial circumflex femoral vessels 
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PATHOPHYSIOLOGY OF DIABETIC ULCER FOOT 
The pathophysiology of diabetic foot is due to the following factors 
• Neuropathy 
• Angiopathy 
• Mechanical stress  
• Faulty wound healing 
• Metabolic derangement 
• Patient and provider‘s neglect 
 
PATHWAY TO DIABETIC FOOT ULCER 
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DIABETIC NEUROPATHY 
 
Polyneuropathy is one of the commonest complications of Diabetes .Most 
common among neuropathies in patients with diabetes are chronic sensorimotor 
distal symmetric polyneuropathy and the autonomic neuropathies. 
Sensory deficit starts in the lower limb distally and progresses to involve feet 
and legs in a ‗stocking‘ pattern. This is followed by the upper extremeties in a 
‗glove‘ like pattern. Diabetes affects autonomic nervous system also. As the 
disease progresses wasting of the small muscles of the hand and asthenia of the 
limb occurs. Sensory loss is the main clinical symptom. Some patient may 
experience tingling, burning pain , shooting pain down the legs. Neuropathic 
pain is nocturnal and causes insomnia. They may develop postural 
hypotension, depressive symptoms . A paradoxical feature is that both pain 
and numbness may co-exist in the same limb, a phenomenon aptly named as 
‗painful, painless‘ leg. The former is due to C fibre damage and the latter due 
to A fiber damage. The commonest clinical presentation is reduced sense of 
vibration in the toes. Ankle jerk is absent and with advancement of disease knee 
reflex also gets involved. Capillary circulation is an important component, the 
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alteration of which, can lead to neuropathy. Vasa Vasorum involvement hinders 
the clearance of metabolic end products from the tissue and also prevents 
nutrient delivery, thereby producing nerve damage . Autonomic neuropathy 
leads to hypohidrosis and predisposes to breakage of dry skin.  The 
‗purely‘ neuropathic foot is actually warm because of abnormal A-V shunting. 
This abnormal increase in blood flow can lead to neuropathic oedema.  The 
American Diabetologist  Association recommends screening for neuropathy,  at 
the time of diagnosis and for autonomic neuropathy five years after initial 
diagnosis in Type 1 and at the time of diagnosis in Type 2 Diabetes followed by 
annual screening thereafter. 
Diabetic polyradiculopathy is a neurological manifestation characterized by 
disabling pain along the course of one or more nerve roots. Truncal 
radiculopathy causes pain over the thorax and abdomen. Involvement of the 
lumbar plexus or femoral nerve may cause severe pain in the thigh or hip and 
have diabetic amyotrophy. All these are usually self-limiting and resolve over 
6-12 months. 
Mononeuropathy is less frequently seen compared to polyneuropathy.  It 
presents with pain and paresis along the distribution of a particular nerve. 
Involvement of Occulomotor Nerve is most common, heralded by diplopia. 
Examination shows ptosis, opthalmoplegia with normal pupil reaction to light. 
4th , 6th and 7th cranial nerves may be affected. Peripheral mononeuropathies 
with concomitant affliction of more than one nerves may occur. 
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Autonomic neuropathy can involve multiple systems. Cardiovasular 
effects include tachycardia at rest and orthostatic hypotension. Gastroparesis 
and bladder voiding abnormalities may be seen. Diabetic cystopathy is the 
inability to sense bladder fullness and failure to empty the bladder completely. 
It can cause impotence and sexual dysfunction in both male and female. 
Increased sweating of the upper extremities and anhydrosis of the lower 
extremities may occur. Anhydrosis leads drying and crackling of feet which 
increases chances of ulcer formation. Peripheral neuropathy plays a key role in 
the events leading on to amputation. 
 
PROPOSED HYPOTHESIS OF DIABETIC NEUROLOGICAL 
DAMAGE 
• Nerve Ischaemia 
• Protein kinase c activation 
• Free radical injury 
• Metabolic pathway hyperactivity eg. Polyol pathway 
• Nerve Regeneration abnormalities 
• Chronic High circulating glucose levels 
 
CHARCOT FOOT  
Charcot neuroarthropathy is manifested by joint dislocations without 
major trauma and pathological fractures.It is of idiopathic origin. The concept 
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by Virchow states that bony changes were due to unperceived sub-clinical 
trauma that are usually not noticed due to insensitivity of the joint. There is 
reduced bone density in the foot in patients with Charcot neuropathy. The 
earliest clinical manifestation is swelling of the foot with pain or discomfort. 
The study by Boykao et al, found relationship between ulcer and charcot 
deformity, but other foot deformities were not independent ulcer predictors. 
Acute Charcot foot may be mistaken for gout, cellulitis, and osteomyelitis. 
Plain radiographs will show bone and joint destruction and loose bodies. Three 
Phase  99mTc bisphosphonate demonstrates active Charcot process. The 
treatment given to Charcot foot patients are prolonged immobilization using 
total contact cast,  Charcot restraint orthotic walker(CROW), 
Schotchcast boot(SCB),and  Pneumatic walking braces. 
 
ANGIOPATHY 
Diabetes can affect both macro and microcirculation. In patients with 
Diabetes, atherosclerosis develops at an early age. Medial calcification, Diffuse 
intimal fibrosis and Atherosclerosis are the most common macrovascular 
changes observed with Diabetes. The most common risk factors associated to 
vascular component are dyslipidemia, hypertension, duration of Diabetes, 
severity of the disease, smoking, Insulin resistance. Moss and colleagues said 
that current smokers less than 30 years of age were more prone to ulcerate. 
Cessation of smoking is associated with a decrease the atherogenic process. 
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Hypertension is almost twice common in diabetics compared to non-diabetics. 
Arteriosclerosis, specific diabetic microangiopathy and diabetic 
fibrillosis are the micro vascular changes observed with Diabetes. The typical 
histological changes are thickening of capillary basement membrane, 
proliferative changes in arterioles and arteries which include enlargement and 
proliferation of endothelial cells. Enlargement of endothelial cell is a feature in 
diabetes leading to small vessel occlusion, causing foot ulceration  termed 
‗small vessel disease‘ with the presence of palpable pulses in the foot. 
Increased resting blood flow due to denervated sympathetics causing loss of 
vasoconstriction, with loss of regulation in circulation in the arterio-venous 
vessels. A ‗capillary steal‘ phenomenon is induced leading to shunting of blood 
away from the capillaries leading to reduced skin nutrition. This explains 
paradoxical ulceration despite increased blood flow. 
 
PERIPHERAL VASCULAR DISEASE 
Peripheral vascular disease occurs at an early age in diabetic patients . It 
is highly likely to involve vessels below popliteal artery. The mechanism by 
which vascular disease causing lesion of nerves are ischemia caused by 
occlusion of vessels, altered permeability of capillaries causing osmotic and 
metabolic derangements. In western countries, vascular alterations is an 
important factor for foot ulcerations causing major amputations later . Minor 
trauma and antecedent infections increase blood requirement beyond the 
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capacity, leading to ischemia and ulceration. Patients presents with intermittent 
claudication, rest pain and nocturnal pain. Nocturnal pain and rest pain are 
relieved by keeping legs in dependent position. The circulation is predominantly 
caters to the splanchnic area during sleep, resulting in decreased perfusion of 
the lower extremities resulting in ischemic neuritis that disturbs sleep. The 
features of the ischemic limb are cold feet with absent pulses, delayed venous 
filling with blanching on elevation. There is loss of hair, thickened nails, and the 
skin appears shiny. Clinical assessment of the peripheral circulation is 
extremely useful in the assessment of outcome. 
 
FAULTY WOUND HEALING 
• Due to prolonged persistence of the abscess 
• Poor granuloma formation 
• Presence of bullae, necrobiosis 
• Fungal infection of the nail 
• High rate of carriage of staph.aureus in the nares and nails 
 
METABOLIC DERANGEMENT 
Hyperglycemia in diabetics impair the complement fixation, ketosis impairs the 
leukocyte function, monocyte mediated immune functions are diminished, and 
alteration in polymorphonuclear leucocyte function leading to deficient wound 
healing. Abnormal glucose levels and toxic metabolites play a role.. 
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HAEMATOLOGY 
Plasma viscosity, Platelet activity, Haemotocrit , red cells and white 
blood cells deformability are altered in diabetic patients. These changes 
profoundly influence the ischemic process. 
 
INFECTION 
Infections in the foot are common with diabetics. Uncontrolled infection 
may progress to amputation. Even with advancement in the treatment, 
uncontrolled sepsis cause about  60% of the lower extremity amputation . In 
patients with gangrene due to diabetes amputations is the treatment. Moist 
gangrene is most common in diabetic patients. Diabetic patients without 
infection, the prognosis is better than patients with infection. If the bones are 
involved, the risk of amputation is around eight times than those with 
involvement of soft tissue alone. Fungal infections are common in the web 
space in the diabetics. Infections may occur in the nailbed. Preventing cross 
infection influences the outcome. 
The descriptions of the involved region is by 
• Severity 
• Extent of the involvement  
• Clinical appearance 
• Location 
• Etiology 
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There are two categories: 
• Non-limb threatening 
• Limb threatening 
• Extensive infections that threaten limb or life require prompt 
hospitalization and appropriate treatment. 
Foot infections occur at the site of trauma or ulceration. If there is a 
breach in the epidermis, colonisation of the bacteria occur in the dermis and the 
underlying tissues. Usually the inflammatory signs are absent around the 
wound. They may present with symptoms like fever, nausea, and fatigue. They 
may present with unexplained increase in the blood sugar levels. If these 
features are found, sepsis should be suspected. 
The lesions should be thoroughly examined to rule out exposed bones, 
joints and tendon sheaths. Failing to do so will result in rapid progression and 
involvement of deeper structures. The spread through tendon sheaths occurs 
both proximally and distally. Gold standard for diagnosing ulcer with infection 
is punch or tissue biopsy since the culture of the wound are often misleading 
and may not represent the organism within the underlying granulation tissue. 
 
The severity of the infections are assessed by 
• analyzing depth of the wound, 
• presence of ischemia, 
• the presence of infection 
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In the presence of osteomyelitis, bone sampling and sensitivity testing become 
minimum required procedures to prevent progression to more aggressive stages 
of the disease 
 
BIOMECHANICS OF FOOT 
 
Biomechanics is a science that deals with effect of forces acting on living 
tissues. The major cause of ulcer formation in diabetics is loss of pain 
sensitivity. Most of the non-healing ulcers are not caused by super-added 
medical conditions, but due to presence of basic biomechanical factors. 
Progressive elevation of plantar pressure is a reliable predictor of ulcer 
formation. Biomechanical factors play pivotal role in all phases of 
management of foot ulcers starting from prevention level to tertiary expert care 
level. 
 
STRESS AND STRESS CONCENTRATION 
 
The mean pressure acting at the feet of a 100kg individual is about 75 
kilopascals. Dynamic pressures are higher compared to static pressures and 
simple  walking. Shearing stress also has a key part in the evolution of ulcers. 
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NEUROPATHY AND HIGH PRESSURE  
 
Peripheral neuropathy results in loss of sensations that confer protection 
against injury. This loss is severe enough that patients may not even perceive 
severe trauma such as penetrating injury to the feet or even scalding caused by 
boiling water or burns. Disuse atrophy predisposes to ulceration. High pressure 
areas that frequently ulcerate include toes and head of metatarsals. Pressure 
applied repeatedly over the same areas especially those overlying bony 
prominences in the setting of profound sensory loss causes ulcer formation that 
starts from within out ie, from bone to the outer soft tissue. Callus are often 
found on inspection. They have a dark base indicative of an underlying deep 
ulcer which bleeds and stains the deep surface of the callus. 
 
INTRINSIC FACTORS CAUSING ELEVATED PRESSURE 
• Changes in foot architecture like long second metatarsal 
• Increased angle of foot arches 
• Soft tissue lesions like callus, clawing of toes due to fat pad migration 
leaving bony prominences exposed 
• Limited joint mobility 
EXTRINSIC FACTORS CAUSING ELEVATED PRESSURE 
• Poor foot wear 
• Ill fitting shoes 
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• Non compliant soles 
• Prior surgery 
 
ACTIVITIES CAUSING ELEVATED PRESSURE 
• Bare foot walking 
• Improper shoes 
• Improper foot care 
• Altered gait 
 
FOOT ULCER DEFINITION & CLASSIFICATIONS OF 
DIABETIC FOOT 
The International consensus currently defines a ― foot ulcer‖ in the diabetic 
patients as a ―full-thickness wound below the ankle , irrespective of the 
duration‖. 
 
Classifications: 
The International Working Group On Diabetic Foot recommends use of a 
uniform classification system to 
• Enable universal understanding among health care providers 
• Provide accurate assessement of healing potential 
• Standardize management protocols 
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• Eliminate observer variations 
• Should be universally acceptable and usable. 
Universally used classification is WAGNER‘S CLASSIFICATION33 
Diabetics possess a life time risk of around 15% for possible ulcer 
formation. 
 
WAGNER CLASSIFICATION 
Grade 0 - No ulcer but high risk foot ( deformity or cellulitis) 
1- superficial diabetic ulcer 
2 - ulcer extends to ligaments, tendons, joints, capsule or deep fascia 
without abscess and /or osteomyelitis 
3 – deep ulcer with abscess/ osteomyelitis/ joint sepsis 
4 - gangrene localized to portion of fore foot 
5 - extensive gangrenous involvement of entire foot 
 
This  most  valuable  grading  for  the  diabetic  ulcer  foot  designed  by 
William Wagner. It is also known as WAGNER-MEGITT‘S 
CLASSIFICATION.  This  system  help  to  analyze  the  progress of  the 
patient, both positive and negative outcomes,  and to standardize  the treatment 
plan. 
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CLASSIFICATION – UNIVERSITY OF TEXAS 
Aetiology (Stage) included - 
Staging 
–Stage A: No  infection  or  ischemia 
–Stage B: Infection  present 
–Stage C: Ischaemia  present 
–Stage D: Infection  and  ischaemia  present. 
Grading 
–Grade 0: Epithelialized  wound 
–Grade 1: Superficial  wound 
–Grade 2: Wound  penetrates  to  tendon  or  capsule 
–Grade 3: Wound  penetrates  to  bone  or  joint 
 
The  other  classification  is  SAD system,  which  adds  to  the  Texas system  
the  cross-sectional  area  and  the  presence  of  neuropathy  or  not. 
 
The „PEDIS‟ system includes 
• Perfusion (ischaemia) 
• Extent 
• Depth 
• Infection 
• Sensation (neuropathy) 
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More recently, International Working Group on Diabetic Foot ( IWGDF ) has 
created a classification that grades wound size ,perfusion of foot, the presence 
of infection, and the presence of sensation.The flaw in all classifications is that 
none of these systems considers the duration of the foot ulcer, which has great 
bearing on healing. 
 
 
ASSESSMENT  OF  DIABETIC  FOOT  ULCER 
Proper assessment of diabetic foot involves adequate history, clinical 
examination and investigations. 
 
HISTORY 
• MEDICAL HISTORY 
1. Diabetes – Duration 
2. Treatment history 
3. Co-morbidities 
4. Nutrition 
5. Addictions 
6. Current drug intake 
7. Hypersensitivities 
8. Past Medical or surgical history 
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• GENERAL HISTORY 
1. Everyday activities 
2. Foot Protection 
3. Callus formation 
4. Bony deformities of the foot 
5. Neuropathic symptoms 
6. Claudication or rest pain 
 
• WOUND/ ULCER HISTORY 
1. Area involved 
2. Number of months involved 
3. Precipitating cause 
4. Previous involvement in the same site 
5. Infection 
6. Hospitalization 
7. Wound care 
8. Wound healing 
9. Patient adherence to advice 
10. Social problems hampering adequate wound care 
11. Previous foot trauma or surgery 
12. Presence of pedal edema 
13. Charcot arthroneuropathy 
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CLINICAL EXAMINATION 
                        All diabetic patients who present to any physician will require a 
detailed foot inspection and examination at least annually. Patients who are 
having diabetic foot related complaints need to be evaluated in detail. 
Systematic examination is mandatory so that we should not overlook any 
important aspects. All the key components required for a detailed foot 
examination are summarized in a bulletin format. In addition to that patient‘s 
vital signs and assessment of his/her general condition is also mandatory even 
though it is not mentioned here specifically. 
 
Examination of vascular system  
1. Palpation of peripheral pulses (dorsalis pedis, anterior tibial, posterior 
tibial, popliteal, femoral) 
2. Sub papillary venous plexus filling time (normal <3 seconds) 
3. Venous filling time (normal <20 seconds) 
4. Color changes: Cyanosis, Dependent rubor erythema 
5. Edema 
6. Temperature gradient 
7. Dermal thermometry 
8. Integumentary changes consistent with ischemia: 
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x Atrophy of skin 
x Atrophy of nail 
x Abnormal wrinkling 
x Loss of hair 
 
Examination of nervous system 
1. Vibration perception 
         Tuning fork 128Hz 
Measurement of vibration perception threshold (Biothesiometer) 
2. Light pressure : Semmes-Weinstein 10 gram monofilament 
3. Light touch : Cotton wool 
4. Two-point discrimination 
5. Pain : Pin-prick 
6. Temperature perception : Hot and cold 
7. Deep tendon reflexes : Ankle, knee 
8. Clonus testing 
9. Babinski test 
10. Rhomberg‘s test 
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Examination of musculoskeletal system 
1. Evaluation of Biomechanical abnormalities 
     Orthopedic deformities 
     Hammertoes 
     Bunion(s) or Tailor‘s bunion(s) 
     Flat or high arched feet 
     Charcot deformities 
     Iatrogenic deformities (e.g, amputations) 
     Restricted joint mobility 
     Tendo-Achilles contractures/equines 
2. Evaluation of gait 
3. Testing of muscle group strength 
      Passive and active, non-weight bearing and weight bearing Foot drop 
      Atrophy – intrinsic muscle atrophy 
4. Assessment of plantar pressure 
                Computerised devices 
                Harris ink mat 
 
Examination of skin and appendages 
1. Appearance  of  skin : Color,  texture,  turgor,  quality dry skin. 
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2. Calluses : Discoloration/subcallus hemorrhage 
3. Fissures (especially posterior heels) 
4. Appearance  of  Nail : Onychomycosis,  dystrophic,  atrophy,  
hypertrophy,  paronychia 
5. Presence/absence  of  hair 
6. Ulceration, gangrene, infection (Note location, size, depth, infection, etc) 
7. Interdigital  lesions 
8. Fungal  infections  like  Tinea pedis 
9. Markers  of  diabetes 
       Shin spots – diabetic dermopathy 
       Necrobiosi  lipoidica  diabeticorum 
       Bullosum  diabeticorum 
        Granuloma  annulare 
 
Examination  of  footwear 
1. Type  of  shoe 
2. Fit  
3. Shoe  wear,  patterns  of  wear 
4. Lining  wear 
5. Foreign  bodies 
6. Insoles 
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Communication  and  Classification  of  Cumulative  Risk 
Following  a  detailed  diabetic  foot  examination,  the  patient  is  
classified  based  on  cumulative  risk   category.  This  helps  the  doctor  to  
design  a  treatment  plan  which  will  reduce  lower  extremity  amputations  
and  reduce  the  patient  from  a  high - risk  category  to  the  lowest  risk  
level.  Several  risk  stratification  schemes  have  been  proposed  assigning   
different  weights  to  various  risk  factors  such  as  peripheral  neuropathy,  
arterial  insufficiency,  deformity,  high  plantar  pressures  and  previous  
history  of  ulceration  or  amputation.  International  working  group  has  
accepted   the  following   simplified  risk  categorization  system. 
                                         
                                            Table 2 
                              Risk categorization system 
Category                         Risk  Profile                                Evaluation  Frequency  
 
0                            No neuropathy                                       Annual 
1                            Neuropathy                                            Semi - annual 
2                            Neuropathy, PVD and/or deformity      Quarterly 
3                            Previous ulcer or amputation                 Monthly to quarterly              
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LABORATORY STUDIES: 
Blood sugar levels 
HB% 
Renal function test 
TC/DC 
ESR 
CRP 
Complete lipid profile 
Urine sugar &deposits 
Urine acetone 
 
Imaging  studies 
The  complex  nature  of  diabetic  foot  disease  along  with  its  
complications  predispose  it  to  various  infections  and  non – infectious  
process.  Hence  imaging  presentations  are  more  likely  to  vary  because  of  
lack  of  specificity  in  complex  clinical  situations.  Obviously  it  will  be  a  
great  challenge  to  interpret  the  imaging  studies  in  diabetic  foot  disease.  
Hence  these  imaging  studies  should  be  restricted  to  confirm  a  diagnosis  
and  to  treat  the  patients. 
Plain X – rays  are  always  the  first  imaging  study  in  diabetic  
patients  who  are  presenting  with  signs  and  symptoms  of  foot  ulcer.  X-ray  
finding  in  diabetic  foot  infection  for  example  osteomyelitis  will  not  be  
able  to  demonstrate  in  an  obvious  osseous  changes  for  upto  two  weeks.  
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Plain  X-rays  are  mainly  indicated  to  detect  osteomyelitis,  osseolysis,  
fractures/dislocations  seen  in  neuropathic  arthropathy,  arterial  calcification  
and  soft  tissue  gas  shadows. 
The  role  of  CT  scans  come  in to  play  only  when  X-rays  do not  
show  any  suspected  bone  or  joint  pathology.  CT  scan  provides  high  
anatomical  details  and  resolution  of  bone  with  osseous  fragmentation  and  
also  subluxation  of  joints  are  visualized  better.  Though  99Technitium  scan  
lacks  specificity  in  neuropathic  patients,  they  are  also  used  in  evaluation  
of  diabetic  foot  infections.  For  early  detection  of  osteomyelitis,  fracture,  
charcot‘s  arthropathy  the  three  phase  bone  scans  are  beneficial.  All  these  
imaging  modalities  when  combined  with  other  scintigraphic  procedures  
like  WBC scans  have  a  higher  specificity.  Gallium 67  citrate  is  used  
along  with  99Tc  scan  to  help  in  the  diagnosis  of  osteomyelitis   and  acute  
osteo arthropathy. 
Indium 111  leukocyte  scans,  TcGG-labelled  white  cell  scan  have  
high  sensitivity  and  specificity  to  distinguish  between  osteomyelitis  and  
neuropathic  arthropathy.  Even  though  these  investigations  are  costly  and  
time  consuming,  they  are  available  in  most  of   the  hospitals  which  aim  at 
an  early  identification  of  bone  infections.  MRI  scan  is  also  used  in  
evaluating  soft  tissue,  bone,  pathologies.  Indications  for  MRI  are  
osteomyelitis,  deep  seated  abscesses,  septic  arthropathy  and  tendon  
rupture.  MRI  has  high  sensitivity  for  bone  infection  and  it  is  readily  
available.  It  can  be  used  for  planning  surgical  interventions.  Even though  
it  is  costlier,  MRI  has  been accepted  widely  in  the  treatment  of  diabetic  
foot ulcers. 
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Vascular Procedures 
           Whenever  there  is  ischemia  and/or  a  non  healing  ulcer  with  absent  
peripheral  pulses,  further  non-invasive  arterial  studies  are  warranted.  They  
should  be  performed  to  determine  perfusion  in  lower  limbs.  They  include  
arterial  Doppler  study,  ankle  brachial  pressure  index,  toe  pressure,  
transcutaneous  oxygen  tension.  Sometimes  ankle  pressures  may  be  falsely  
elevated  due  to  calcification  of  tunia  media  of  the  arteries  and  also  the  
affected  arteries  may  be  non-compressible.  In  such  cases  the  ankle  
brachial  pressure  index  may be  misleading.  Toe  blood  pressures  have  a  
role  in   predicting  the  diabetic  patients  who  are  at  risk  for  foot  ulceration  
and  also  in  the  prediction  of  successful  wound  healing.  Trans-cutaneous  
oxygen  tension  measurement   has  also  received  similar  kind  of  supports  
in  the  previous   publications.  When  it  is  less  than  25mmHg,  it  predicts  
that  there  will  be  failure  of  proper  tissue  oxygenation  and  there  are  more  
chances  of  poor  wound  healing.  These  two  tests  can  be  performed  
distally  on  the  foot  regardless  of   calcification  of  pedal  arteries.  The  
favourable  range  of  pressure  is  around  40mmHg. 
Laser Doppler  velocimetry  is  useful  in  assessment  of  skin  perfusion  
pressure  and  blood  flow  velocity  in  superficial  arterioles  and  capillaries  of  
skin.  At  levels less  than  30mmHg  it  is highly  predictive  of  critical limb  
ischemia  and  poor  wound  healing.  Digital  subtraction  
angiography/magnetic  resonance  angiography  are  the  other  modalities  used  
to  evaluate  distal  arterial  perfusion. 
 
Neurologic  Procedures 
            Biothesiometer  is  used  to  assess  the  vibration  perception  threshold.  
This  is  also  useful  to  predict  the  patients  who   are  having  high  risk  for  
58 
 
ulceration.  Nerve  conduction  studies  are  also  useful  to  diagnose  peripheral  
sensory  neuropathy.  Patients  who  are  having  neuropathic  ulceration  always  
have  a  profound  sensory  neuropathy. 
 
Plantar  Foot  Pressure Assessment 
               High  plantar  foot  pressure  is  an  important  risk  factor  for  foot  
ulcerations.  Various  modalities  are  used  to  measure  the  plantar  foot  
pressures.  There  are  many  computerized  systems  which  quantitatively  
measure  the  plantar  foot  pressures.  They  identify  the  foot  which  are  at  
risk  of  ulceration  and  also  evaluate  the  orthotic  adjustments.  Harris  mat,  
it  is not  only useful  in  qualitative  measurement  of  plantar  pressure  but  
also  useful  in  identifying vulnerable  areas  of  ulceration. 
 
Assessment  of  diabetic  wound  infections 
              During  evaluation , a proper  detailed  history  taking  and  physical  
examination  should  be  done  in  all  cases.  Complete assessment  of  these  
patients  can  be  achieved through  a  systematic  approach. 
             The  past  history  of  patients  about  any  pre –existing  comorbidities  
should  be  obtained.  Treatment/drug  history  is  also  important.  Since  most  
of  the  diabetics  have  associated  peripheral  neuropathy,  pain  is  not  a  
reliable  symptom  in  these  patients.  History  of previous  ulcertaions,  
infections,  injury ,  surgery  at  the  present  site  should be  obtained.  Patients  
with  the  infected  diabetic  foot  can  have  constitutional  symptoms  such  as- 
i. Fever 
ii. Chills 
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iii. Nausea 
iv. Vomiting 
v. Malaise 
vi. Fatigue 
In  about  50  to  60%  of   diabetic  patients,  who  have  severe  infections  the  
systemic  signs  such  as  fever  and  leukocytosis  are  absent.  Recalcitrant  
hyperglycemia  is  the  only  indicator  of  infection  in  certain  diabetic  foot  
patients  where  systemic  signs  are  absent 
 
Laboratory investigations 
i. Complete  blood  count 
ii. Total  and  differential  counts 
iii. Blood  culture  and  sensitivity 
iv. Estimation  of  glycated  haemoglobin 
v. Fasting/post prandial  blood  glucose 
vi. Erythrocyte  sedimentation  rate 
vii. Urine  ketone  bodies  
viii. Renal  function  tests 
ix. Routine  urine  analysis 
The  patients  should  be  asked  about  the  mode  of   onset,  duration  of  the  
ulcer  and  appearance  of  area  before  infection. 
 
Examination  of  the  ulcers  include 
i. Size  of  ulcer 
ii. Shape 
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iii. Margins 
iv. Depth 
v. Floor 
vi. Base 
vii. Discharge  if  any 
viii. Swelling 
ix. Color  of  the  surrounding  skin 
x. Odour 
xi. Extent  of  the  ulcer 
xii. Presence  or  absence  of  slough 
 
Probing  of  the  ulcer  should  be  done  to  determine 
i. Bone  and  joint  involvement 
ii. Sinus  tract 
iii. Extension  into  tendon  sheets 
 
            The  extension  into  tendon  sheets  is  the  most  common  route  of  
spread  of  infection  proximally  and  distally.  If  the  bone  gets  exposed  it  is  
presumed  that  there  is  underlying  osteomyelitis  unless  proved  otherwise .  
Swab  should  be  taken  from  the  ulcer  base  and  should  be  sent  for  
culture.  This  will  help  to  minimise  the  false  negative  results  and  to  
identify  the  true  pathogen  involved  in  ulcer  causation.  Nowadays  tissue  
culture  holds  good  results  compared  to  conventional  pus  culture. 
             Bone  culture  should  be  taken  in case  of  osteomyelitis  in  order  to  
arrive  at  a  definite  diagnosis  and  to  plan  appropriate  treatment. There  is  a 
possibility  of  contamination  of  non-infected  bone  when  there  is active  soft  
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tissue  infection.  As  already  mentioned  imaging  studies  plays  a  vital  role  
in  overall  assessment  of  diabetic  foot  infection.   
             Plain  X-rays  shows  presence  of   bony  erosion  and /or  soft  tissue  
gas  shadows.  The  demonstration  of  osteomyelitis  by plain  X-rays  lags  the  
onset  of  bony  involvement  by  10  to  14  days.   Tc99  bone  scans  may  
demonstrate  abnormal  uptake  of  radionuclides  before  obvious  changes  are  
visible  on  plain  radiographs. 
             But  Tc99  scans  lags  specificity  in  patients  having  peripheral  
neuropathy  or  having  any  pre-existing  osseous  conditions   which  causes  
increased  bone  turnover (surgery,  fracture,  neuropathic  arthropathy).  Tc99  
scan  and  indium  labelled  leukocyte  scan  and  Tc99 HMPAO  labelled  scans  
are  the  combination  of  scans  which  are  helpful  in  distinguishing  between  
osteomyelitis  and  charcot‘s  arthropathy. 
             MRI  scan  has  higher  tissue  contrast  and  so  it  is  very  useful  to  
detect  both  soft  tissue  and  bone  marrow  inflammation.  MRI  scan  can  
also  be  used  in  the  follow  up  of  resolution  of  infection  and  also  used  in  
planning  surgery.  All  the  imaging  modalities  which  are  mentioned  above  
do  not  have  100%  sensitivity  and  specificity  to  diagnose  bone  infection.  
In  addition  to  that  these   imaging  modalities  are  not  readily  available  and  
also  very  costly.  Hence  proper  clinical  assessment  is  the  mainstay   of  
planning  management. 
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MANAGEMENT OF  DIABETIC  FOOT  ULCERS 
 
General  principles  and  goals 
              The  main  aim  in   the  treatment  of  diabetic  foot  ulcer  is  to  obtain  
wound  closure  as  early  as  possible.  In  diabetic  patients  the  rate  of  lower  
limb  amputation  can  be  reduced  by  treatment  of  foot  ulcer  and  reducing  
the  rate  of  occurrence.  The  treatment  objectives are  summarized  as  
follows 
i. Appropriate  wound  management 
ii. Debridement 
iii. Management  of  ischemia  and  infection 
iv. Pressure  relief (off-loading) 
v. Surgical  management 
vi. Management  of  comorbidities 
 
Treatment of diabetic foot infections are divided into non-limb threatening and 
threatening infections. 
 
Non -limb threatening infections 
         To define, these are medically stable patients having no signs of systemic 
sepsis. They are ideal candidates for outpatient management under close 
supervision. 
        Clinically, these group of patients have superficial ulcers with minimal 
ischaemia and lack bone or joint involvement. Cellulitis is confined to within 
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2cm of the ulcer margins. Many of these cases are monomicrobial with 
staphylococcus aureus, staphylococcus epidermiditis and beta hemolytic 
streptococci being the most common ones to be isolated. Samples for cultures 
are acquired by curettage of the infected ulcer. Oral antibiotic therapy is 
initially given. MRSA should be covered under the spectrum. The ulcer should 
be debrided as often as necessary. 
 
Limb-threatening infections 
This group includes 
• Cellulitis beyond 2cm of ulcer margin 
• lymphangitis 
• Ischemic Tissue necrosis 
• Odour 
• Gangrene 
• Bone involvement 
      
      These patients require emergent hospital admission and appropriate 
intervention. The patient‘s co-morbidities should be evaluated. Extent of 
infection should be thoroughly assessed. A team approach in treatment 
improves outcomes. 
           Initial management by a surgeon includes debridement, drainage of toxic 
fluid  or pus, decompression by fasciotomy or limited amputations to curtail 
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progress of infection. During this, wide range of culture specimens should be 
obtained to identify bacteria and fungal growth. Sub-Arachnoid Blocks should 
be avoided in these patients. 
The presence of hemodynamic imbalance or profound systemic compromise 
should not deter the surgeon from taking up debridement. Only clearance of 
infected tissue will improve the internal milieu of the patient. Most of such  
cases have poly-microbial infections requiring intravenous antibiotics initially  
rather than oral medication. Osteomyelitis should be evaluated radiologically  
and microbiologically. Debridement of the infected bone and even minor 
amputations may be needed. Bone cement containing antibiotics are available 
for use after adequate debridement,  provided adequate soft tissue cover is 
available. 
 
DRESSINGS 
Dressings are done to keep the wound clean and free. It removes excess 
bacteria from the wound. It removes excess fluid. Materials used should not 
cause toxicity to the wound. It should be non-adhesive. Various types are 
1. Honey dressing- provides moisture, decreases odour, reduce 
inflammation, reduce oedema and exudates. 
2. Silver-containing dressings- Silver is having broad spectrum of activity. 
It kills yeast, fungi, viruses and methicillin and vancomycin strains. 
3. Iodine-Dressings. 
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4. Hydrocolloid Dressings- Create moist healing environment, should not 
be used in heavily infected wound 
5. Alginate dressings- Derived from sea weed, have the capacity to absorb 
large amounts of exudates. 
6. Hydrogels- Promote autolytic wound debridement in dry wounds, absorb 
exudates in moist wounds. 
7. Hyalofill- Derivative of hyaluronic acid, should be used on clean wounds. 
8. Living skin equivalents- Dermagraft or graftskin. 
 
LARVAL THERAPY 
Maggots are living chemical factories. Worms remove dead tissues by the 
production of a mixture of proteolytic enzymes that breakdown dead tissue to a 
semi-liquid form ingested by creatures, stimulate fibroblast growth in vitro, 
eliminate odour and reduce wound related pain. 
 
GROWTH FACTORS 
Growth factors play a key role, regulating all aspects of wound healing. 
Epidermal growth factor(EGF), fibroblast growth factor 2 (FGF-2) and platelet 
derived growth factor(PDGF) all have been approved in the treatment of 
diabetic foot ulcers. 
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OFFLOADING THERAPY 
The choice of technique is based on the physical form and compliance 
with the treatment, and also site and severity of the ulcer. The aim is to reduce 
dynamic foot pressure. 
Total contact cast (TCC) is gold standard in management. Total contact 
cast should not be used in patients with local sepsis and vascular compromise. 
Other options are Removable cast walkers, Charcot restraint orthotic walkers, 
Healing sandals and half shoes, felted foam padded dressings, therapeutic shoes 
and insoles. 
This line of management should be continued till there is complete 
healing of ulcers. 
 
SURGICAL INTERVENTION 
It is often indicated for deep infection or for the treatment of recurrent or 
recalcitrant ulceration. They include debridement of recalcitrant or infected 
ulcers, drainage and debridement of soft tissue infection,bone resection for 
relief of pressure and or for osteomyelitis; closer techniques; Achilles 
lengthening surgery; and reconstruction of forefoot deformities. Primary or 
delayed closure is advocated as more effective, much more cost-efficient and 
successful. Low pressure or vacuum assisted closure is particularly valuable 
when there is insufficient soft tissue surplus to allow for primary closure of the 
wound edges. 
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DEBRIDEMENT 
Debridement serves several purposes: 
• Excision of dead tissues and callus. 
• Pressure alleviation 
• Ulcer bed assessment 
• Probing of tracks and tunnels 
• Decreasing microbiological load 
There are Five types of debridement 
• Surgical 
• Enzymatic 
• Autolytic 
• Mechanical 
• Biological 
Early surgical intervention by debridement has been demonstrated to be 
the best. 
 
SURGICAL DEBRIDEMENT 
Aggressive removal of the devitalized tissues is done by sharp scissors 
and scalpels. Extent of debridement should be sufficient enough to reach all 
margins of infection both in the deeper plane and also in the horizontal plane. 
The aim of this approach is to convert a chronic non-healing wound into an 
actively bleeding acute wound that will have the capacity to granulate and 
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regenerate. Deep seated abscess mandates hospitalisation and immediate 
incision and drainage. Removal of bones either locally or by limited 
amputations may be necessary. Repeated removal of necrotic tissue expedites 
rate of healing. This is known as as ―maintenance debridement‖. 
 
Hydro surgery 
Its properties are 
• Precise and 
• Limited Excision 
• Negligible thermal damage to the tissues. 
An extremely painful wound may benefit from enzymatic debridement. 
Vascular wounds are candidates for enzymatic debridement. 
 
MOISTURE BALANCE 
Moisture accelerates re-epithelization in a wound. Tissue moisture is a 
term used to convey the importance of keeping wounds moist and free of excess 
fluids. A moist wound environment promotes granulation and autolytic 
processes. Effective management of chronic wound fluids is an essential part of 
wound bed preparation. It also helps in addressing the issues of cellular 
dysfunction and biochemical imbalance. 
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ADVANCES IN WOUND CARE 
Preparation of ulcer bed enables removing barriers which hinder healing 
and to start the healing process. Advanced care sometimes becomes the only 
means of attaining wound closure. The discovery of recombinant growth 
factors, genetic manipulation, artificial tissues, stem cell therapy have 
empowered the surgeon and wound-care provider to aid in angiogenesis to 
accelerate healing. 
 
VAC THERAPY 
Delivery of intermittent or continuous sub-atmospheric pressure through 
a specialized pump connected to open-celled foam surface dressing covered 
with an adhesive drape to maintain a closed environment. It increses blood 
flow, decreases local tissue edema, removes excessive fluid and 
proinflammatory exudates from the wound bed. 
 
AMPUTATIONS 
Amputations, an unpleasant but often final end result of the diabetic foot. 
It is performed for multiple reasons and can be either curative or emergent. 
Amputation level selection aims at achieving balance between preservation of 
limb length and function with the ability of the wound to heal properly. 
Currently available vascular surgical advances have made ‗limb sparing‘ 
more and more feasible. Endovascular restoration of vascularity have made it 
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possible to do more distal amputations. Pre amputation vascular intervention 
must be done to limit level of amputation and also to facilitate proper stump 
healing. 
 
AIM OF DECIDING LEVEL OF AMPUTATION 
• To leave behind a stump that can readily accept prosthetic shoe, orthotic 
device or complete limb prosthesis 
• To create a stump that is less likely to breakdown from external pressures 
• To prevent dynamic imbalances that may occur due to migration of digits 
such as in migration of the other digits after 1st MTP joint disarticulation, 
varus deformity that occurs due to lateral loading of the foot following 5th 
Toe Ray amputation. 
• To facilitate primary wound healing so as to enable rapid healing of the 
stump and early rehabilitation of the amputee. 
If infections are not controlled or due to the advancement in the disease 
process, diabetics usually succumb to lower extremity amputation. The 
incidence of amputations for non-traumatic etiologies is ten times higher in 
Diabetes. Costs of amputation and its descendent managements are very high. 
This is due to length of hospitalization that is required and due to 
multiple investigations and repeated surgical and vascular interventions that 
may be required. 
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Various amputations of lower extremity are 
• Ray‘s amputation 
• transmetatarsal (Gillies) 
• tarsometatarsal (lisfranc‘s) 
• midtarsal(chopart‘s) 
• syme‘s 
• Below-knee(Burgess) 
• Transcondylar 
• above-knee 
The three most common indications for major lower extremity 
amputations are 
• acute limb ischaemia 
• chronic critical limb ischaemia 
• major infection due to malperforans ulcers in diabetics with normal 
arterial circulation. 
 
GOALS 
The goals of major lower extremity amputations are : 
• to eliminate the nonviable tissue 
• to provide a stump with best chance to heal 
• to provide a stump with best chance of long term function-ambulation 
with prosthesis. 
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IDEAL STUMP 
• The ideal stump should heal adequately 
• should have rounded ,gentle contour with adequate muscle padding 
• should have adequate length to bear prosthesis 
• should have thin scar which does not interfere with prosthetic function 
• should have adequate joint movement 
• should have adequate blood supply. 
 
GENERAL PRINCIPLES APPLICABLE TO AMPUTATION SURGERY 
 
SKIN 
Flaps should be sutured in a tension free manner and the scar should be 
well healed and non-adherent to the bone. 
 
MUSCLE 
Myodesis should be performed to facilitate balanced action of opposing 
muscle groups. 
 
NERVE 
Neuroma formation should be prevented by dividing the nerve at a higher 
level by applying adequate traction and allowing it to retract into the stump 
under cover of muscles. Nerves should never be ligated. 
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BLOOD VESSELS 
Visible bleeding alone does not indicate optimum level of amputation. Wound 
healing in reality is dependent on micro-circulation. Vessels must be 
suture ligated, arteries and veins in separate group to avoid iatrogenic AV 
fistula formation. 
 
BONES 
Bone should be cut at a higher level and ends beveled so as to avoid 
protruding bone that will interfere with healing of stump and also result in a 
painful end bearing stump. 
 
STUMP DRESSINGS 
A cotton wool followed by crepe bandage is commonly used dressing for 
the amputation stump. A rigid cast support  enables wound protection, 
contracture prevention and oedema reduction. 
 
TYPES OF AMPUTATION 
 
RAY AMPUTATION 
Amputation of the toe with the head of metatarsal or metacarpals. 
TRANSMETATARSAL AMPUTATION (GILLIES‟) 
Amputation is done proximal to the neck of the metatarsals, distal to the base. 
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LISFRANC‟S AMPUTATION (TARSOMETATARSAL) 
Here tarsometatarsal joint is disarticulated with a long volar flap. 
CHOPART‟S AMPUTATION (MIDTARSAL) 
Here talonavicular and calcaneocuboid joints are disarticulated. Tibialis 
anterior is sutured to the drilled talus bone. A long volar flap is used and 
immobilized for six weeks after surgery. 
SYME‟S AMPUTATION 
It is removal of the foot with calcaneum and cutting tibia and fibula just 
above the ankle joint with retaining heel flap (dividing both malleoli).Heel flap 
is supplied by medial and lateral calcaneal vessels . Elephant boot is used for 
the limb after syme‘s amputation. Many patients walk well with syme‘s stump 
without difficulty. It is presently mainly used in trauma(crush injuries) and 
malignancies of the distal part of the foot. 
PIROGOFF‟S AMPUTATION 
It is like syme‘s amputation except the posterior part of the calcaneum is 
retained along with heel flap. It provides longer stump than syme‘s amputation. 
TRANSTIBIAL(BELOW-KNEE) AMPUTATION 
Knee joint is spared. The ideal stump is 15cms long 
The advantages of preserving the knee joint are 
• lower kinetic energy requirement 
• near normal gait 
• Ease of using prosthesis 
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• Self Sufficiency and reduced dependancy 
• Quicker rehabilitation 
• Less expensive prosthesis 
KNEE DISARTICULATION(THROUGH-KNEE) AMPUTATION 
It is through the joint and does not disturb the bone. It is used in patients 
with poor general condition and those who are not amenable to prosthetic 
mobilization 
TRANSFEMORAL(ABOVE-KNEE) AMPUTATION 
About 12-15cm of lower end of femur should be removed. Usually equal 
anterior and posterior flaps are used. If femur length less than 10cms this 
procedure is not possible. If femur length is less than 10 cms, then should 
proceed with hip disarticulation. The marked reduction in limb length 
drastically reduces propulsive power and manipulation of the prosthesis. 
Efficient ambulation depends solely on the user‘s ability to mobilize the 
artificial knee joint in the prosthesis. 
 
CURATIVE VERSUS EMERGENT SURGERY 
Performance of amputation in the elective setting may not always be a 
possibility. When serious infections such as gas gangrene are starting to set in, it 
becomes mandatory to perform an emergency amputation. Before surgical 
intervention, pre-existing infection should be dealt with. Elective amputations 
are usually curative ie, primary wound healing is facilitated by raising flaps and 
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closing the wound primarily. Emergency amputations aim at removal of 
necrotic tissue only and not at healing the stump primarily. Subsequent surgery 
may be required to close the wound once the infection has been controlled. 
 
COMPLICATIONS OF AMPUTATION SURGERY 
 
Early complications: 
• Hemorrhage 
• Infection 
• Haematoma 
Late complications: 
• Pain 
• Flap necrosis 
• Ring sequestrum formation 
• Ulceration of the stump 
• Painful scar 
• Phantom limb 
 
POSTOPERATIVE PERIOD AFTER AMPUTATION 
• Regular physiotherapy 
• Regular dressing 
• Crutch is used initially 
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• After 3 months prosthesis is used 
• Rehabilitation 
 
Prevention  of  recurrence  of  ulcer 
           Always  prevention  is  better  than  cure.  A multidisciplinary  team  
approach  is  essential  for  the  prevention  of  recurrence  of  ulcer.  The team  
compromises  of   
1. Podiatric  surgeon 
2. Internist 
3. Endocrinologist 
4. General  physician 
5. Cardiologist 
6. Vascular  surgeon 
7. Orthopaedic  surgeon 
8. Nephrologist 
9. Neurologist 
10. Physiotherapist 
11. Pedortist 
12. Attending  nurse 
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HEALTH  EDUCATION 
            Health  education  of  the  patients  regarding   
1. Foot hygiene 
2. Daily  self  inspection  of  wounds 
3. Wear  proper  fitting  footwear 
4. Prompt  treatment of  new  ulcers 
5. Regular  hospital  visits 
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OBSERVATION  AND  RESULTS 
TOTAL  NUMBER  OF PATIENTS – 120 
CONSERVATIVELY MANAGED – 76 
MAJOR  AMPUTATIONS – 35 
x Amputation  at  trans  tibial  level ( below  knee amputation )  or  higher. 
MINOR  AMPUTATIONS – 9 
x Toe  disarticulation 
x Ray amputation 
x Mid-tarsal amputation 
x Tarso-metatarso  amputation 
 
 
35, 29%
76, 63%
9, 8%
MANAGEMENT
AMP CONS MINOR
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1. AGE  DISTRIBUTION 
        Age distribution  of  120  cases studied  at  Govt.  Rajaji  hospital,  
youngest  patient  was 35 yrs  old,  eldest  patient  was  75 yrs  old.  Highest  
number  of  cases  were  found  in  the  age  group  of  61-70. 
   
AGE CONSERVATIVE AMPUTATION MINOR 
<50 9 14 0 
51-60 17 12 3 
61-70 39 7 4 
>70 11 2 2 
 
       By  age  distribution,  patients  with  younger  age  tend  to  have  
aggressive  disease.  
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2. SEX  DISTRIBUTION 
           Out  of  120  patients  96  were  male  and  24  were  female. 
SEX CONSERVATIVE AMPUTATION MINOR 
Male 62 27 7 
Female 14 8 2 
 
           Males  are  more  commonly  affected  in  diabetic  foot  infections 
and amputation  rates  are  also  higher  compared to  females. 
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3. PRESENCE  OF  GANGRENE 
         PRESENCE OF GANGRENE CONSERVATIVE AMPUTATION MINOR 
NIL 41 0 0 
MINIMAL COLOR CHANGE 35 0 9 
(+)(+) COMPLETE GANGRENE 0 35 0 
 
100%  of  patients  with  complete  gangrene  are  going  for  amputation. 
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4. PULSE  STATUS  OF THE  CONCERNED  PART 
PULSE STATUS OF CONCERNED 
PART CONSERVATIVE AMPUTATION MINOR 
(+)(+) 37 0 0 
(+) 39 0 9 
(-) 0 35 0 
 
100%  of  patients  with  absent  pulse  are going  for  amputations.  
In case  of  weak  pulse,  out  of  48  patients,  9  are  going  for  minor  
amputation 
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5. ANKLE  BRACHIAL  INDEX 
ABI 
CONSERVATIVE AMPUTATION MINOR 
0.9-1.1 (38) 
38 0 0 
0.9-0.3 (47) 
38 0 9 
<0.3 (35) 
0 35 0 
 
In  case  of  ABI, critical  limb  i.e. less  than  0.3 - 100%  unsalvageable 
 
 
0
5
10
15
20
25
30
35
40
0.9-1.1 (38) 0.9-0.3 (47) <0.3 (35)
38 38
00 0
35
0
9
0
ABI VS MANAGEMENT
CONS AMP MINOR
87 
 
6. BONY  INVOLVEMENT 
BONY INVOLVEMENT CONSERVATIVE AMPUTATION MINOR 
NIL 72 18 0 
OSTEOMYELITIS (+) 4 17 9 
 
In  case  of  bony  involvement  i.e.  Osteomyelitis,  out  of  30  patients  more  
than  50%  are  going  for  amputation  and   more  than   25%  are  going  for  
minor  amputation. 
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7. INFECTIONS 
INFECTIONS AMPUTATION 
NIL 0 
MONOMICROBIAL 1 
POLYMICROBIAL 34 
 
Infections  tend  to  be  more  severe  in case  of  polymicrobes.  Out  of  
35  amputations,  34  are  infected  with  polymicrobes.  Klebsiella  
species  is  the  predominant  infection  in  our  locality. 
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8. MICROBIOLOGICAL  TISSUE  CULTURE 
MICROBIOLOGICAL TISSUE CULTURE AMPUTATION 
COAGULASE  NEGATIVE  STAPH. AUREUS 6 
E.COLI 3 
KLEBSIELLA SP. 16 
PSEUDOMONAS SP. 1 
STAPH. AUREUS 9 
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9. ANTIBIOTIC  SENSITIVITY/ RESISTANT  PATTERN 
ANTIBIOTIC SENSITIVITY AMPUTATION 
NO RESISTANCE 0 
RESISTANT TO ANY DRUG 35 
 
In  all  those  35  amputations,  the  organisms  were  resistant  to  atleast  
one  drug. 
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Antibiotics 
 
No of resistant strains 
MRS 
spp 
(n=10) 
 
 
MSS 
spp 
(n=3
0) 
 
Streptococcus 
spp 
(n = 8) 
P. 
aeruginosa 
(n = 5) 
 
K. 
pneumoniae 
(n=35) 
E.coli 
(n =8) 
Enterococci 
spp (n=4) 
Actinomycetes 
spp (n=3) 
Proteus 
spp 
(n=4) 
 
Amikacin 
(30mcg) 
5 4 1 2 12 2    
Ampicillin 
(10mcg) 
7 5 2 
 
4 22 6    
Ampicillin/ 
Sulbactam (10 by 
10) 
4 1 3 3 17 2    
Azithromycin 
(15mcg) 
4 8 2 2 21 1    
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Carbenicillin 
(100mcg) 
4 7 1 3 9 4    
Cefazolin 
(30mcg) 
5 3 2 0 13 4    
Cefepime 
(30mcg)  
4 7 2 2 10 3    
Cefaperazone 
(75mcg) 
5 2 2 1 10 3    
Ceftizoxime 
(30mcg) 
8 7 1 2 9 4    
Cefuroxime 
(30mcg)  
7 5 1 0 9 4    
Chloramphenicol 
(30mcg) 
2 4 1 3 8 2    
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Gatifloxacin 
(5mcg)  
2 2 2 2 4 3    
Lomefloxacin 
(10mcg) 
6 19 3 3 10 5    
Meropenem 
(10mcg)  
5 2 1 1 3 1    
Nitrofurantoin 
(300mcg)  
0 1 2 2 8 2    
Penicillin 
(10mcg) 
9 3 2 3 18 2    
Ticacillin/Clavula
nic acid 
5 2 3 2 11 5    
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From the table  it is clear that there are some organisms showing high resistance to the antibiotics. Those organisms 
showing more than 50% resistant strains are highlighted in bold.  
More than 50% of the MRS spp showed resistance to Ampicillin (10mcg), ceftizoxime (30 μg), cefuroxime (30 μg), 
lomefloxacin (10 μg) and penicillin (10 μg). 
While more than 50% of the MSS spp showed resistance to  lomefloxacin (10 μg). Gram – positive Streptococcus spp 
showed reasonably good sensitivity to all the tested antibiotics with very little resistance seen.  
In the Gram – negative aerobes more than 50% of the K.pneumoniae strains showed resistance to ampicillin (10 μg), 
Ampicillin/ Sulbactam (10 by 10), azithromycin (15 μg) and Penicillin (10mcg). More than 50% of the E. coli strains 
showed resistance to ampicillin (10 μg), lomefloxacin (10 μg) and ticarcillin/clavulanic acid (75 by 10).  
 
Common organism and their antibiotic sensitivity pattern in our locality 
• Klebsiella species- Cefuroxime/ Ceftizoxime/ Meropenem 
• Staph. aureus- Cefaperazone Sulbactam/ Amoxyclav. Acid/ Meropenem 
•  Coagulase negative Staph. aureus- Cefepime 
• E.coli- Cefaperazone Sulbactam/ Azithromycin/ Meropenem 
• Pseudomonas species- Cefuroxime/ Cefaperazone Sulbactam/ Amikacin 
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10. DURATION  OF  DIABESTES 
DURATION OF DIABETES AMPUTATION 
LESS THAN 1YR 0 
1-5yr 5 
MORE THAN 5YRS 30 
 
    Risk  of  amputation  increases with  increase in  duration  of  Diabetes. 
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11. HAEMOGLOBIN 
HB% AMPUTATION 
>8gms 10 
<8gms 25 
 
      Out of  35 amputations, amputation  tendency  increases  with  fall  in  Hb%. 
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12. TOTAL  WBC  COUNT 
TC AMPUTATION 
<10000 cells/cumm 0 
10000-15000 cells/cumm 13 
>15000 cells/cumm 22 
 
Total  count  reflects  the  rate  of  wound  infection  and  hence  
amputation  rate  increases  with  increase  in  TC. 
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13. C-REACTIVE  PROTEIN 
CRP AMPUTATION 
<0-10mg/dl 3 
>10mg/dl 32 
 
CRP  denotes  the  acute  severity  of  infection. Out  of 35  amputations,  
32 patients  had  elevated  CRP. 
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14. ERYTHROCYTE  SEDIMENTATION  RATE 
ESR AMPUTATION 
<20mm/hr (8 patients) 0 
20-100mm/hr (106 
patients) 29 
>100mm/hr (6 patients) 6 
 
In  case  of  ESR<20mm/hr,  all  patients  were  managed  conservatively  
while patients  with  ESR>100mm/hr  went  for  amputation. 
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15. LIPID  PROFILE (LDL) 
LIPID PROFILE (LDL) AMPUTATION 
<100mg/dl (80 patients) 10 (29%) 
>100mg/dl (40 patients) 25 (71%) 
 
Lipid profile  plays  an  important  role  in influencing  diabetic  foot  
amputation.  Out  of  the total  35  amputees, 10 had <100mg/dl  of  LDL  
level  whereas  25 had  >100mg/dl. 
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16. CARDIAC  STATUS 
CARDIAC STATUS CONSERVATIVE AMPUTATION MINOR 
NORMAL ECHO STUDY 65 11 4 
LVEF<50% 11 24 5 
 
           A  decrease  in  Ejection  fraction  compromises  peripheral  blood  
supply  which  in  turn  leads  to  poor  oxygenation  to  the  tissues  and  
aggrevates  infections.  In  almost  60% of  amputed  patients  LVEF  is less 
than 50%. 
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MADURAI MEDICAL (MM) SCORING SYSTEM FOR 
ANALYSING MAJOR CONTRIBUTING FACTORS FOR LOWER 
LIMB AMPUTATIONS IN DIABETIC FOOT INFECTIONS 
  
0 1 2 
PRESENCE OF 
GANGRENE NIL 
MINIMAL COLOR 
CHANGE 
(+)(+) COMPLETE 
GANGRENE 
PULSE STATUS OF 
CONCERNED 
PART 
(+)(+) (+) (-) 
ABI 0.9-1.1 0.9-0.3 <0.3 
BONY 
INVOLVEMENT NIL   
OSTEOMYELITIS 
(+) 
INFECTIONS NIL MONOMICROBIAL POLYMICROBIAL 
DURATION OF 
DIABETES LESS THAN 1YR 1-5yr MORE THAN 5YRS 
ANTIBIOTIC 
SENSITIVITY NO RESISTANCE   
RESISTANT TO 
ANY DRUG 
HB% >12gms 8-12gms <8gms 
TC <10000 cells/cumm 
10000-15000 
cells/cumm 
>15000 
cells/cumm 
ESR <20mm/hr 20-100mm/hr >100mm/hr 
CRP <0-10mg/dl 10-15mg/dl >15mg/dl 
LIPID PROFILE 
(LDL) <100mg/dl 100-189mg/dl >190mg/dl 
     CARDIAC 
STATUS 
NORMAL  ECHO  
STUDY LVEF<50% 
LV THROMBUS; 
EF<40% 
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CONCLUSION 
The  conclusion  derived  from  the  above  observation  are: 
1. The following  factors  are the  major  contributory/predictive  factors  for 
amputation in  Diabetic  foot  patients - 
x Presence  of  gangrene 
x Pulse  status  of  concerned  part 
x Ankle  brachial  index 
x Presence of  osteomyelitis 
x Soft  tissue Infections 
2. The  minor  contributory/predictive  factors  for  amputation  in  Diabetic  
foot  patients - 
x Haemoglobin  status 
x Total  white  blood  cell  count 
x Erythrocyte  sedimentation  rate 
x C-reactive  protein 
x Lipid profile (LDL) 
x Cardiac  status 
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Conclusion  of  Madurai  Medical (MM) Scoring  system - 
SCORE SURGICAL MANAGEMENT 
13 & BELOW DEBRIDEMENT ALONE 
14-17 MINOR AMPUTATION 
18 & ABOVE NON-SALVAGEABLE 
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CASE PROFORMA 
 NAME : 
 AGE/SEX : 
 ADDRESS : 
 PHONE NO : 
 COMPLAINTS : 
 SITE OF INVOLVEMENT : 
 HISTORY OF CLAUDICATION PAIN : 
 HISTORY OF NUMBNESS/LOSS OF SENSATION : 
 HISTORY OF TRAUMA : 
 HISTORY OF FOUL SMELLING DISCHARGE : 
 HISTORY OF PREVIOUS SURGERY : 
 DRUG HISTORY : 
 FAMILY HISTORY : 
 DIET HISTORY : 
 GENERAL EXAMINATION : 
 LOCAL EXAMINATION : 
x INSPECTION : 
x PALPATION : 
x PULSE STATUS : 
x ABI : 
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 DIAGNOSIS :  
 INVESTIGATIONS : 
x Hb%: 
x Tc/Dc: 
x Creatinine: 
x ESR: 
x CRP: 
x Lipid profile:  
x X-Ray: 
x Echocardigram:  
x Bacteriological tissue culture: 
x Monomicrobial: 
x Polymicrobial: 
x Antibiotic Sensitivity Patterns: 
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S.N
o. 
NAME 
AGE/ 
SEX 
IP No. 
GAN
GRE
NE 
PULS
E 
STAT
US  
ABI 
BONY 
INVOL
VEME
NT 
INFE
CTIO
NS 
DUR
ATIO
N 
OF 
DIAB
ETES 
ANTI
BIOTI
C 
SENS
ITIVIT
Y 
HB
% 
TC 
E
S
R 
CR
P 
(LDL) 
CA
RDI
AC 
STA
TU
S 
MICROBIOL
OGICAL 
TISSUE 
CULTURE 
SC
ORI
NG 
MANA
GEME
NT 
1 SUBRAMANI 47/M 11177 1 1 1 0 2 1 2 0 1 1 1 0 0 CO.NS 11 CONS 
2 VELUSAMY 49/M 40456 1 0 0 0 2 1 2 1 1 1 1 0 0 CO.NS 10 CONS 
3 AJMERKHAN 35/M 1080885 0 0 0 0 2 1 2 0 1 1 1 1 1 E.COLI 10 CONS 
4 VELUKONAR 60/M 17773 2 2 2 0 2 2 2 2 1 1 1 2 0 CO.NS 19 AMP 
5 MUNIYASAMY 50/M 1053663 2 2 2 0 2 2 2 1 2 1 1 1 1 KLEB SP. 19 AMP 
6 MEENAKSHI 55/F 76771 0 0 0 0 1 1 0 2 1 0 0 0 0 CO.NS 5 CONS 
7 KOTHAIAMMAL 80/F 79696 1 1 1 2 2 1 2 1 1 1 1 1 1 KLEB SP. 16 MINOR 
8 SHANMUGAVEL 45/M 1082152 0 0 0 0 2 1 2 1 1 1 1 1 0 CO.NS 10 CONS 
9 AYYAPAN 50/M 1057491 2 2 2 0 2 2 2 2 2 2 1 1 0 S.AUREUS 20 AMP 
10 THIRUMALAI 48/M 1056439 0 0 0 0 1 1 1 1 1 1 0 0 0 CO.NS 6 CONS 
11 MOOKAMAL 60/F 78231 2 2 2 2 2 2 2 0 1 1 1 0 1 S.AUREUS 18 AMP 
12 DHANALAKSMI 35/F 79760 1 1 1 0 2 1 2 0 1 1 1 0 2 S.AUREUS 13 CONS 
13 SELVARAJ 55/M 1088271 1 0 0 0 2 0 2 1 1 1 1 1 1 CO.NS 11 CONS 
14 SITHUPANDI 48/M 1120943 2 2 2 0 2 2 2 2 2 1 1 1 1 S.AUREUS 20 AMP 
15 JANAKI 44/M 75731 1 1 1 0 2 1 2 2 1 1 1 0 0 E.COLI 13 CONS 
16 JAYAMANI 60/F 16781 1 0 0 0 2 1 2 1 1 1 1 1 0 CO.NS 11 CONS 
17 NAGENDRAN 55/M 1092231 0 0 0 0 1 0 0 1 1 0 0 0 0 KLEB SP. 3 CONS 
18 BALASUBBU 56/M 1125429 1 1 1 2 2 1 2 1 1 1 1 0 0 CO.NS 14 MINOR 
19 RAGHU 42/M 50293 0 0 0 0 2 1 2 0 1 1 1 1 0 S.AUREUS 9 CONS 
20 KANNAN 50/M 1135441 2 2 2 0 2 2 2 2 2 2 1 1 1 CO.NS 21 AMP 
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21 ANANDHAM 45/M 287 1 1 1 0 2 2 2 1 1 1 1 0 0 PSE.SP. 13 CONS 
22 MANIMARAN  42/M 1140096 2 2 2 2 2 2 2 1 2 1 1 0 1 CO.NS 20 AMP 
23 MEENAKSHI 70/F 58821 1 1 1 0 2 1 2 1 1 1 1 0 0 KLEB SP. 12 CONS 
24 PALANIAMMAL 50/F 1096694 2 2 2 2 2 2 2 2 1 1 1 1 0 S.AUREUS 20 AMP 
25 SEENIAMMAAL 65/F 37793 1 0 0 0 2 1 2 2 2 1 1 0 0 PSE.SP. 12 CONS 
26 SUBBAIYA 65/M 1135123 0 0 0 0 1 0 2 1 1 1 1 1 0 E.COLI 8 CONS 
27 VEERAPAN 68/M 58710 1 1 1 0 2 1 2 1 1 1 1 1 0 CO.NS 13 CONS 
28 SUBRAMANI 54/M 1142021 2 2 2 0 2 2 2 1 2 1 1 1 1 S.AUREUS 19 AMP 
29 KARUPPAIYA 65/M 1110742 2 2 2 0 2 2 2 2 1 1 1 1 2 E.COLI 20 AMP 
30 VARADHARAJ 64/M 1101145 2 2 2 2 2 2 2 1 1 1 1 1 1 S.AUREUS 20 AMP 
31 MARIAMMAL 55/F 1115674 0 1 1 2 2 1 2 1 1 1 0 1 0 E.COLI 13 CONS 
32 LAKSHMANAN 61/M 53456 1 1 1 0 2 1 2 1 1 1 0 0 0 KLEB SP. 11 CONS 
33 KALIAPPA 58/M 1111245 1 1 1 0 2 1 2 1 1 1 0 0 0 S.AUREUS 11 CONS 
34 VASANTHAM 64/F 15634 1 1 1 0 2 1 2 1 1 1 0 1 0 CO.NS 12 CONS 
35 JAYAMANI 60/F 31566 2 2 2 0 2 2 2 2 2 2 1 1 1 CO.NS 21 AMP 
36 PERIYASAMY 69/M 1118765 0 0 0 0 0 1 2 1 1 1 0 0 0 E.COLI 6 CONS 
37 KULANDHAIVEL 72/M 1118976 0 0 0 0 2 1 2 0 1 1 0 0 0 S.AUREUS 7 CONS 
38 NATARAJA 75/M 1115321 2 2 2 0 2 1 2 2 1 1 1 1 2 KLEB SP. 19 AMP 
39 NADARAJAH 59/M 56453 0 0 0 0 2 1 0 0 1 0 0 0 0 KLEB SP. 4 CONS 
40 RAVINDRAN 74/M 1119864 0 1 0 0 2 1 2 1 1 1 0 0 0 CO.NS 9 CONS 
41 JOHN PETER 43/M 11304 2 2 2 0 2 2 2 2 2 1 1 0 1 KLEB SP. 19 AMP 
42 RAMAKRISNAN 66/M 52678 0 0 0 0 2 1 2 1 1 1 0 0 0 PSE.SP. 8 CONS 
43 VADIVELU 60/M 1115674 1 1 1 2 2 1 2 1 1 1 0 0 0 KLEB SP. 13 CONS 
44 SAVITHRI 63/F 1117635 1 1 1 0 2 1 2 1 1 1 0 1 1 CO.NS 13 CONS 
45 CHINNASAMY 55/M 145221 2 2 2 0 2 2 2 2 2 1 1 1 1 KLEB SP. 20 AMP 
46 GOUNDER 50/M 48281 2 2 2 2 2 2 2 2 2 1 1 0 0 S.AUREUS 20 AMP 
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47 DHARMAN 57/M 1118078 2 2 2 2 2 1 2 2 1 1 1 1 0 E.COLI 19 AMP 
48 KATHIR 65/M 14534 1 1 1 0 2 1 2 1 1 1 0 0 1 KLEB SP. 12 CONS 
49 CHITRA 65/F 1111546 0 1 1 0 1 1 2 1 1 1 0 1 0 CO.NS 10 CONS 
50 SOLAIRAJA 64/M 34562 1 1 1 0 2 1 2 1 1 1 0 0 0 S.AUREUS 11 CONS 
51 RAMALINGAM 59/M 1115632 1 1 0 0 2 1 2 1 1 1 0 0 0 KLEB SP. 10 CONS 
52 ANNAMAYIL 35/F 147623 2 2 2 0 2 2 2 2 2 1 1 1 1 KLEB SP. 20 AMP 
53 ANANDHASAMY 61/M 1114367 1 1 1 0 2 1 2 1 1 1 0 0 0 CO.NS 11 CONS 
54 XAVIER 60/M 53423 1 1 1 2 2 1 2 1 1 1 0 0 0 KLEB SP. 13 CONS 
55 SAKTHIVEL 58/M 1113456 0 0 0 0 0 0 1 0 1 0 0 0 0 S.AUREUS 2 CONS 
56 SIVAGAMI 60/F 1198231 0 1 1 0 2 1 2 2 1 1 0 1 0 KLEB SP. 12 CONS 
57 PANDIRAJ 62/M 1117634 0 0 0 0 2 2 2 2 1 0 0 0 0 CO.NS 9 CONS 
58 KRISHNASAMY 63/M 147623 2 2 2 0 2 2 2 1 2 2 1 1 0 KLEB SP. 19 AMP 
59 BHARATHI 59/F 143871 1 1 1 2 2 2 2 2 1 1 0 0 0 PSE.SP. 15 MINOR 
60 ANANDHI 62/M 1114567 2 2 2 0 2 2 2 2 2 1 1 1 1 KLEB SP. 20 AMP 
61 ANNADURAI 65/M 1114598 0 1 1 0 2 2 2 2 1 1 0 0 0 CO.NS 12 CONS 
62 KARPAGAM 66/F 34287 0 0 0 0 2 1 2 1 1 1 0 0 0 KLEB SP. 8 CONS 
63 KALAMARAN 72/M 1134982 0 0 0 0 2 1 2 2 1 1 0 0 0 S.AUREUS 9 CONS 
64 SARAVANAN 70/M 1123467 1 1 1 2 2 1 2 1 1 1 0 0 1 KLEB SP. 14 MINOR 
65 SIVANESAN 69/M 1128761 1 1 1 0 2 1 2 1 1 1 0 0 0 CO.NS 11 CONS 
66 VANITHA 65/F 1118124 2 2 2 2 2 2 2 2 1 1 2 1 1 S.AUREUS 22 AMP 
67 MUTHUSAMY 73/M 1123657 1 1 1 0 2 1 2 2 1 1 0 0 0 E.COLI 12 CONS 
68 DURAIRAJ 70/M 1125673 0 1 1 0 2 1 2 1 1 1 0 0 0 CO.NS 10 CONS 
69 KANNAIYA 60/M 1126745 1 0 1 0 2 1 2 1 1 1 0 0 2 KLEB SP. 12 CONS 
70 MUTHUPANDI 46/F 1126943 2 2 2 2 2 2 2 2 1 1 0 1 1 KLEB SP. 20 AMP 
71 SYED ALI 71/M 1124578 0 0 0 0 1 0 2 1 0 1 0 0 0 CO.NS 5 CONS 
72 RAMASAMY 68/M 1122342 0 0 0 0 2 1 2 0 1 1 0 0 0 KLEB SP. 7 CONS 
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73 MOORTHI 52/M 1127551 2 2 2 0 2 2 2 2 2 1 1 0 1 KLEB SP. 19 AMP 
74 KRISHNAMURTHY 64/M 1124576 1 1 1 0 2 1 2 2 1 1 0 0 0 CO.NS 12 CONS 
75 PAULRAJ 65/M 1124567 0 0 0 0 2 1 2 1 1 1 0 0 0 KLEB SP. 8 CONS 
76 ABDUL HAMEED 70/M 1125567 1 1 1 0 2 1 2 1 2 1 0 0 0 CO.NS 12 CONS 
77 TAMILVANAN 40/M 1128895 2 2 2 0 2 2 2 2 2 2 1 1 1 S.AUREUS 21 AMP 
78 CHELLAM 60/F 1127902 2 2 2 2 2 2 2 1 1 1 1 0 1 E.COLI 19 AMP 
79 KANNAGAVEL 72/M 1122348 1 1 1 0 2 1 2 2 2 1 0 0 0 E.COLI 13 CONS 
80 KUMARASAMY 69/M 1123367 0 1 1 0 2 1 2 1 1 1 0 0 0 CO.NS 10 CONS 
81 VENKATACHALAM  68/M 112387 1 1 1 0 2 1 2 1 1 1 0 0 2 KLEB SP. 13 CONS 
82 AIAGAR 64/M 1124702 2 2 2 2 2 1 2 2 2 1 1 0 1 KLEB SP. 20 AMP 
83 KRISHNAN 56/M 1127836 2 2 2 0 2 1 2 2 2 1 1 1 0 KLEB SP. 18 AMP 
84 MAILUSAMY 69/M 1125675 1 1 1 0 2 2 2 1 1 1 0 0 0 CO.NS 12 CONS 
85 ALAMELU 59/F 1125648 0 0 0 0 1 2 2 1 0 0 0 1 0 KLEB SP. 7 CONS 
86 VETRIVEL 69/M 1126756 1 1 1 2 2 2 2 2 1 1 0 0 0 PSE.SP. 15 MINOR 
87 PANDI 63/M 1126788 0 0 0 0 2 2 2 0 1 1 0 0 0 KLEB SP. 8 CONS 
88 THAGAPANSAMY 70/M 1127891 1 1 1 0 2 2 2 0 1 1 0 0 0 CO.NS 11 CONS 
89 AYYER 65/M 1120384 2 2 2 2 1 1 2 1 2 2 1 0 0 KLEB SP. 18 AMP 
90 VAITHISWERAN 66/M 1128976 0 1 1 0 2 2 2 2 1 1 0 0 0 KLEB SP. 12 CONS 
91 MURUGESAN 60/M 58070 2 2 2 0 2 2 2 2 2 1 1 1 1 KLEB SP. 20 AMP 
92 THANGARAJ 69/M 1132345 1 1 1 2 2 1 2 2 1 1 0 0 1 CO.NS 15 MINOR 
93 KARIMUTHU 66/M 1135674 1 1 1 0 2 1 2 1 1 1 0 0 0 E.COLI 11 CONS 
94 MARIAM 64/M 1135674 0 0 0 0 1 1 0 1 0 0 0 0 0 KLEB SP. 3 CONS 
95 VELUSAMI 73/M 1135645 0 0 0 0 2 1 2 1 1 1 0 0 0 PSE.SP. 8 CONS 
96 JOHNSON 70/M 1135678 0 0 0 0 2 1 2 2 1 1 0 0 1 KLEB SP. 10 CONS 
97 PATHIRAKALI 51/M 1137683 2 2 2 2 2 2 2 2 1 1 1 0 1 CO.NS 20 AMP 
98 ANBARASU 70/M 1136578 0 0 0 0 2 2 2 2 1 1 0 0 0 KLEB SP. 10 CONS 
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99 ASAIMUTHU 71/M 1136713 1 1 1 0 2 1 2 2 1 1 0 0 0 E.COLI 12 CONS 
100 PETCHIAMAL 45/F 1137866 2 2 2 2 2 2 2 2 2 1 1 1 0 KLEB SP. 21 AMP 
101 JAYARAJ 73/M 1136578 0 0 0 0 2 1 2 1 1 1 0 0 0 CO.NS 8 CONS 
102 RATHNASAMY 71/M 1136798 1 1 1 2 2 2 2 1 1 1 0 0 0 E.COLI 14 MINOR 
103 KUPPANAN 68/M 1137789 0 0 0 0 2 1 2 0 1 1 0 0 0 KLEB SP. 7 CONS 
104 MADASAMY 65/M 1137823 1 1 1 2 2 2 2 0 1 1 0 0 2 KLEB SP. 15 MINOR 
105 IRUDHAYARAJ 69/M 1137589 0 0 0 0 2 1 2 1 1 1 0 0 0 CO.NS 8 CONS 
106 KARUPUSAMY 75/M 1136354 0 0 0 0 2 1 2 2 1 1 0 0 0 KLEB SP. 9 CONS 
107 PERIYAKARUPU 74/M 1138764 0 1 1 0 2 1 2 2 1 1 0 0 0 E.COLI 11 CONS 
108 SHEIK ALI 56/M 1137705 2 2 2 2 2 2 2 2 2 1 1 1 0 KLEB SP. 21 AMP 
109 KARMEGAM 59/M 1136798 1 1 1 2 2 2 2 2 1 1 0 0 1 CO.NS 16 MINOR 
110 SATHYAMOORTHY 50/M 1139994 2 2 2 2 2 2 2 2 1 1 0 1 1 PSE.SP. 20 AMP 
111 VEERAGURU 66/M 1134897 1 1 1 0 2 1 2 1 1 1 0 0 0 KLEB SP. 11 CONS 
112 CHINNAPONNU 69/F 1132467 0 0 0 0 2 1 2 1 1 1 0 1 0 CO.NS 9 CONS 
113 MUTHUKUMAR 45/M 11721 2 2 2 2 2 2 2 1 1 1 1 0 0 KLEB SP. 18 AMP 
114 RAMESH 62/M 1136789 1 1 1 0 2 1 2 1 1 1 0 0 1 CO.NS 12 CONS 
115 ELAMARAN 59/M 1139878 0 1 1 0 2 1 2 1 1 1 0 0 0 CO.NS 10 CONS 
116 GANESAN 60/M 1082341 0 0 0 0 2 0 2 1 1 1 0 0 1 KLEB SP. 8 CONS 
117 MANJULA 60/F 35784 0 0 0 0 2 0 2 1 1 1 0 0 0 KLEB SP. 7 CONS 
118 MANAVALAGAN 65/M 1139087 1 1 1 2 2 1 2 1 1 1 0 0 0 CO.NS 13 CONS 
119 NATARAJAN 72/M 1133542 2 2 2 2 2 2 2 1 2 1 0 1 1 CO.NS 20 AMP 
120 ALAGAMMAL 70/F 37871 1 0 0 0 1 2 0 0 1 0 0 0 1 E.COLI 6 CONS 
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LIST  OF  ABBREVIATIONS: 
1. KLEB SP :  KLEBSIELLA  SPECIES 
2. CO.NS : COAGULASE  NEGATIVE  STAPHYLOCOCCI 
3. E.COLI : ESCHERICHIA COLI 
4. S.AUREUS : STAPHYLOCOCCI AUREUS 
5. PSE SP : PSEUDOMONAS  SPECIES 
6. CONS :  CONSERVATIVE 
7. MINOR : MINOR  AMPUTATION 
8. AMP : MAJOR AMPUTATION 
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